Skip to content
Sunday, November 15, 2026
HubioHub UK

The Zimbabwean Government Turns Down ‘One-Sided’ US Health Aid Agreement Due to Information Apprehensions

Medical funding image
The offered US funding would have supported programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has rejected a major US health deal worth $367m (£272m) spanning five years over Washington's insistence on confidential information.

The decision was revealed after a internal memorandum dated December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".

A government representative has since explained that the US was requesting health data for research and commercial purposes while was unwilling to guarantee the resulting advantages from any future vaccines.

"We must now begin the difficult and regrettable task of ending our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the United States had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has urged further negotiations to find a deal acceptable to both sides so the nation's vital HIV treatment initiative can be sustained.

Broader Implications

This development follows a comparable situation in Kenya, where a high court blocked a related health funding agreement following legal challenges were raised about the safety of Kenyans' medical information.

Since resuming office last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.

The agency had managed aid for the American government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to enhance openness and responsibility.

According to statements, 16 nations in Africa have so far agreed to similar health pacts, constituting over $18.3bn in committed funds.

Specifics of the Rejected Agreement

The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this partnership might have yielded immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment via American-funded initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".

"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, without any equivalent assurance of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," his statement read.

"In essence, our country would supply the raw materials for scientific discovery without any certainty that the end products would be accessible to our population if a new pandemic arise."

National Interest and Global Health

Mangwana further said that the US's withdrawal from the global health body and its push of one-on-one health agreements were undermining frameworks already established through the global health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing system designed to deal with potential global health emergencies.

"This framework is intended to ensure that when a country contributes its data, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the funds to create them."

These objections over the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We encourage ongoing discussions with our American counterparts on how future co-operation might be designed in a way that honours the sovereignty and dignity of each country."

Medical Community Reaction

A leading public health body said it recognised the official position, but urged that negotiations need to persist since much of the country's Aids initiatives were funded by international support.

"Where technical issues exist, including those relating to data governance or implementation frameworks, these can often be resolved via detailed discussion and mutually agreed protections," the group added.

The halted deal highlights the continuing debate between receiving much-needed international aid and protecting local interests in an increasingly interconnected world.

EB
About the author

Elizabeth Bryan

A tech enthusiast and digital strategist with over a decade of experience in emerging technologies and startup ecosystems.

HubioHub UK

Type to search articles.